QNCX vs VTRS · $79.3M cap vs rev $7.27B
Quince Therapeutics, Inc. (QNCX) versus Viatris Inc (VTRS) — a side-by-side from cached financials, not a winner call.
Quince Therapeutics, Inc. (QNCX) is a biotechnology company listed on US.
Viatris Inc (VTRS) is a drug manufacturers - specialty & generic company listed on US.
QNCX does not have a complete income-statement cache yet.
Latest reported VTRS revenue for 2026-06-30 was $7.27B. VTRS currently screens at market cap $10.83B.
QNCX currently screens at market cap $79.3M. VTRS currently screens at market cap $10.83B.
Not investment advice. Open the QNCX and VTRS stock pages for the full models.
Not investment advice.